Weight loss jabs like Ozempic are linked to anxiety and social issues, prompting discussions about microdosing and natural alternatives for effective weight management. Read more...

Novo Nordisk and Eli Lilly are battling it out in the weight-loss drug market with price cuts on Wegovy and Zepbound. Also, investment firms adjust their positions in KKR and Blue Owl. Read more...

This article explores two pressing health issues: the controversy surrounding weight loss injections given to teenagers and the poignant story of a man choosing assisted dying. Read more...

Recent business news covers mortgage implications after house destruction, wealth-building strategies, prescription drug price cuts, and the rise and fall of Forever 21. Read more...

Sikorsky Australia lands a big helicopter deal, a trading platform touts AI, Hims & Hers faces challenges, and Seasalt Cornwall offers denim discounts. Read more...

This week in health: a study on postpartum depression and brain changes, the risks of overhydration, and the potential pitfalls of weight-loss drugs like Ozempic. Plus, a ruling on cosmetic surgery. Read more...

Wes Streeting faces NHS challenges with a three-point plan and calls for retailer accountability after a teen bought weight-loss drugs. Starmer's peace plan also emerges. Read more...